Lower innovative drug costs not being passed on by pharma firms, say Dutch researchers [Advocacy Lab Content]

Lower drug pricing does not follow from an expansion of innovative medicine indications, according to Dutch researchers. They claim pharma companies often fail to pass on their financial gain to patients and health services.